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Abstract
Distal arthrogryposis (DA) is group of syndromes characterized by
congenital joint contractures. Treatment development is hindered by
the lack of vertebrate models. Here, we describe a zebrafish model in
which a common MYH3 missense mutation (R672H) was introduced
into the orthologous zebrafish gene smyhc1 (slow myosin heavy chain
1) (R673H). We simultaneously created a smyhc1 null allele (smyhc1),
which allowed us to compare the effects of both mutant alleles on
muscle and bone development, and model the closely related disor-
der, spondylocarpotarsal synostosis syndrome. Heterozygous
smyhc1R673H/+ embryos developed notochord kinks that progressed to
scoliosis with vertebral fusions; motor deficits accompanied the
disorganized and shortened slow-twitch skeletal muscle myofibers.
Increased dosage of the mutant allele in both homozygous
smyhc1R673H/R673H and transheterozygous smyhc1R673H/ embryos
exacerbated the notochord and muscle abnormalities, causing
early lethality. Treatment of smyhc1R673H/R673H embryos with the
myosin ATPase inhibitor, para-aminoblebbistatin, which decreases
actin–myosin affinity, normalized the notochord phenotype. Our
zebrafish model of MYH3-associated DA2A provides insight into
pathogenic mechanisms and suggests a beneficial therapeutic role
for myosin inhibitors in treating disabling contractures.
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Introduction
Distal arthrogryposis (DA) describes a group of congenital muscu-
loskeletal syndromes characterized by contractures in the joints of the
hands and feet. Classification systems currently describe ten closely
related DA subtypes, the most severe of which is Freeman-Sheldon
syndrome (also called distal arthrogryposis, type 2A [DA2A]). Chil-
dren born with DA2A present with characteristic contractures of the
hands, clubfeet, and facial contractures. They also often develop scol-
iosis (Toydemir et al, 2006; Beck et al, 2013). Complications of DA,
particularly DA2A, include difficulty eating, respiratory complications,
and impaired speech and mobility. Currently, supportive treatments
including bracing, physical therapy, and surgical intervention are the
only therapeutic options for DA patients; however, these therapies are
often suboptimal (Stevenson et al, 2006; Boehm et al, 2008).
The most common genetic causes of DA are autosomal dominant
missense mutations in the MYH3 gene, encoding the embryonic
myosin heavy chain (MyHC) that is expressed first during slow
skeletal muscle development. MYH3 expression peaks during fetal
development, and is significantly downregulated after birth (Chong
et al, 2015; Schiaffino et al, 2015; Cameron-Christie et al, 2018).
MYH3 mutations have been identified in multiple DA syndromes,
including distal arthrogryposis, type 1 (Alvarado et al, 2011),
DA2A, and distal arthrogryposis type 2B (DA2B) (also called Shel-
don-Hall syndrome) (Toydemir et al, 2006; Beck et al, 2013). MYH3
mutations have additionally been identified in patients with multiple
pterygium syndrome (Chong et al, 2015), and spondylocarpotarsal
synostosis syndrome, which is associated with vertebral, carpal,
and tarsal fusions in addition to joint contractures (Carapito et al,
2016; Zieba et al, 2017; Cameron-Christie et al, 2018).
MyHCs are large, dimerizing, ATP-dependent motor proteins that
bundle together in thick filaments to drive muscle contraction. The
most common DA-causing MYH3 mutations cluster in the ATPase
region of the MyHC motor domain (Toydemir et al, 2006; Fitts, 2008).
The dominant inheritance pattern of DA mutations implies a hyper-
morphic, neomorphic, or antimorphic nature. The functional effects
of DA-associated MYH3 missense mutations include slowing the
muscle relaxation time and prolonging the muscle fiber contracted
state (Racca et al, 2015; Walklate et al, 2016). While the vast majority
of described DA mutations are dominant missense variants, the
recent identification of autosomal recessiveMYH3 variants in spondy-
locarpotarsal synostosis syndrome suggests that some mutations may
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also contribute to disease pathogenesis through a loss of function or
hypomorphic mechanism (Cameron-Christie et al, 2018).
Understanding the mechanism by which dominant or recessive
MYH3 mutations cause contractures or bony fusions has been
limited by poor access to human tissue, particularly during early
development when the gene is most highly expressed. Analysis of
muscle biopsies from adults with the MYH3 R672C mutation, which
is one of the most common recurrent variants causing DA2A and
DA2B (Toydemir et al, 2006), revealed increased relaxation time
and impaired sarcomeric cycling (Racca et al, 2015). Recombinantly
expressed MYH3 R672C, R672H, and T178I mutations in cultured
cells also caused marked abnormalities in molecular kinetic proper-
ties including slower cycling time (Walklate et al, 2016). While the
molecular effects of pathogenic MYH3 mutations have been
modeled in Drosophila (Rao et al, 2019), mutations have yet to be
studied in vertebrate models where their impact on muscle and
skeletal development can be concurrently assessed.
To address the need for vertebrate models of DA, we created a
zebrafish line in which the common human DA2A MYH3 mutation,
R672H, was precisely edited into the corresponding amino acid of the
slow myosin heavy chain 1 gene (smyhc1R673H [stl583]) (Roy et al,
2001). This gene is expressed in the somites as early as 5–9 somite
stages, and in the lateral slow muscle of the trunk, as evidenced by
previously conducted in situ hybridization (Rauch et al, 2003; Bessarab
et al, 2008; Li et al, 2020). We simultaneously created a smyhc1 null
allele (smyhc1 [stl582]), which allowed us to compare the effects of
both mutant alleles on slow skeletal muscle and bone development.
Remarkably, the smyhc1 allele in the homozygous state caused
transient muscle abnormalities in larvae and late-onset scoliosis,
whereas the smyhc1R673H allele resulted in notochord kinks, abnor-
mally shortened muscle, and vertebral fusions with the severity of
the phenotype correlating with allele dosage. The early notochord
phenotype was suppressed or normalized with para-aminoblebbis-
tatin, a drug that reduces myosin–actin affinity by inhibiting myosin
ATPase activity, which directly inhibits muscle contraction (Várkuti
et al, 2016). Because removing muscle contraction suppressed the
abnormal notochord phenotype, we interpret this result as support-
ing our hypothesis that the smyhc1R673H allele causes hypermorphic
muscle contraction that creates excessive tension on the developing
zebrafish notochord. This secondarily results in kinking of the noto-
chord that contributes to later vertebral fusions. Furthermore, by
showing that the smyhc1R673H zebrafish model replicates key aspects
of the congenital disorder that can be normalized with myosin inhi-
bitors, we have demonstrated its value for evaluating therapeutics
for use in human DA patients.
Results
smyhc1R673H is an autosomal dominant mutation that acts in a
dose-dependent manner
To study the mechanism by which MYH3 mutations cause DA, we
genetically engineered a mutant zebrafish line in which a single
nucleotide substitution was introduced via homologous recombina-
tion into exon 16 using a donor oligonucleotide and TALENs
(Fig 1A–C). The resultant zebrafish smyhc1R673H missense substitu-
tion is orthologous to a common MYH3 mutation causing DA2A in
humans, R672H (Fig 1A and B). We concurrently generated a zebra-
fish smyhc1/ line containing a frame-shifting seven base pair dele-
tion that is predicted to result in a premature truncation in exon 16
and transcript loss by nonsense-mediated decay. Indeed, Smyhc1
protein expression was not detected in smyhc1/ embryos at
24 hours post fertilization (hpf) when Smyhc1 is normally most
highly expressed in wild-type (smyhc1+/+) embryos (Fig 1C–E). In
contrast, smyhc1R673H heterozygotes and homozygotes produce
detectable Smyhc1 protein, confirmed via immunohistochemistry
staining (Fig 1E). The brief period of Smyhc1 protein expression is
demonstrated by its absence by 48 hpf in smyhc1+/+ larvae on
Western blot (Fig 1D) and in all genotypes by 3 dpf (days post ferti-
lization) as shown by immunohistochemistry (Fig EV1).
Consistent with prior studies that used morpholinos to tran-
siently reduce smyhc1 expression (Codina et al, 2010), smyhc1/
embryos displayed no gross phenotype in larval stages despite being
paralyzed until 48 hpf (described below) (Figs 2A and 5A). In
contrast, we noted that nearly half of the embryos heterozygous for
the smyhc1R673H allele displayed mild notochord kinks or slight
curves in the body axis beginning at 48 hpf, while fewer showed
more severe kinks, often in multiple locations along the body axis.
Furthermore, all homozygous smyhc1R673H/R673H zebrafish mani-
fested severely abnormal morphology and developed multiple noto-
chord bends and kinks that markedly compressed and disfigured the
body axis and were apparent by ~ 30 hpf (Figs 2A and B, and
EV3A). These early notochord kinks resemble those seen in the
accordion zebrafish mutant, which has a muscle relaxation defect
due to a mutation in the sarcoplasmic reticulum Ca2+—ATPase
pump (atp2a1) (Hirata et al, 2004).
To determine whether the presence of a wild-type copy of smyhc1
influences the phenotype of fish harboring a single smyhc1R673H allele,
we crossed smyhc1/ and smyhc1R673H/+ mutant lines. The absence
of a wild-type copy of smyhc1 resulted in more severe morphological
abnormalities. In fact, the phenotype of smyhc1R673H transheterozy-
gous embryos (smyhc1R673H/) was identical to that of smyhc1R673H/
R673H embryos, in which similarly severe notochord kinks and bends
were observed (Fig 2A). The observed partial rescue of the
smyhc1R673H phenotype via dilution of the allele with the wild-type
allele, and the failure of smyhc1R673H homozygotes, heterozygotes, or
transheterozygotes to phenocopy smyhc1/ fish support the hypothe-
sis that the smyhc1R673H substitution is hypermorphic or neomorphic.
smych1R673H mutation is homozygous lethal and reduces survival
of heterozygotes
Because of the disruptive embryonic phenotypes of smyhc1R673H
heterozygotes and homozygotes, we systematically determined the
impact of genotype on survival. Because no smyhc1R673H/R673H indi-
viduals survive to adulthood for breeding, we instead incrossed
smyhc1R673H/+ fish and genotyped the resulting progeny of various
ages to determine the ratio of surviving smyhc1+/+:smyhc1R673H/+:
smyhc1R673H/R673H fish (Fig 3A). In contrast to the expected Mende-
lian ratio of 1:2:1, we discovered that smyhc1R673H/R673H embryos
did not survive past larval stages (Fig 3B). We determined that the
ratio of smyhc1R673H/R673H embryos sharply declined between 1 and
2 dpf, with the remaining homozygotes perishing before juvenile
stages. Many smyhc1R673H/+ fish survive into adulthood and are
fertile; however, survival is reduced compared to wild type, with a
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decline continuing throughout adulthood. The smyhc1R673H allele
increases mortality of the fish in a dose-dependent manner, consis-
tent with the severity of the gross phenotype.
smyhc1/ adults develop late-onset spinal curvature
We noticed an increase in spinal curvature of smyhc1/ fish as they
reached adulthood, and decided to examine the phenotype further.
Despite the apparent short and early temporal expression of smyhc1,
which is strongly expressed at 24 hpf but markedly reduced by 48
hpf (Fig 1D), its disruption has lasting effects into adulthood.
Although smyhc1/ larvae appeared morphologically normal
(Fig 2A), nearly all developed spinal curvatures in adulthood
(Figs 4A and EV2). To determine whether the observed curvature is
associated with vertebral fusions, alizarin red/alcian blue staining of
bone and cartilage, respectively, was performed on adult zebrafish
between 1 and 2 years old. Alizarin red staining of adult smyhc1/
fish revealed variable spinal curvatures along the length of the spine
in both lateral and sagittal planes (Fig 4B). Most smyhc1/ fish
were afflicted with mild-to-moderate curvature (Figs 4C and EV3B).
Despite the apparent curvature of smyhc1/ fish, vertebral fusions
were not observed. This is consistent with the lack of notochord
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Figure 1. Generation of smyhc1 mutant lines and embryonic muscle development.
A Schematic to scale of human MYH3 gene on chromosome 17. Noncoding regions are displayed in pink. Coiled coil domain (840–1,933 bp) displayed in purple. Motor
domain (86–779 bp) displayed in yellow. Actin binding site (656–678/758–772 bp) shown in cyan. Location of R672H mutation is enlarged and labeled.
B Schematic to scale of zebrafish smyhc1 gene on chromosome 24. Noncoding regions are displayed in pink. Coiled coil domain (842–1,929 bp) displayed in purple.
Motor domain (85-778 bp) displayed in yellow. Actin binding site (655–677 bp) displayed in cyan. Location of R672H mutation is enlarged and labeled.
C Aligned DNA and amino acid sequences of MYH3 and smyhc1 alleles surrounding the smyhc1R673H and MYH3 R672H substitutions. The smyhc1 allele has a 7 base
pair deletion that results in a frameshift in which one errant amino acid precedes a premature stop codon. The smyhc1R673H allele results from a G>A transition single
point mutation.
D Western blot of whole zebrafish larvae, Smyhc1 stained with the F59 antibody. smyhc1+/+ larvae express Smyhc1 at 24 hpf, but not at 48 hpf. smyhc1/ larvae do
not express Smyhc1.
E Smyhc1 immunohistochemistry stain of 24 hpf (hour postfertilization) zebrafish larvae. Filamentous actin is stained with phalloidin (red). Nuclei are stained with
DAPI (blue). Smyhc1 is stained with the F59 antibody (green) (Elworthy et al, 2008). smyhc1+/+, smyhc1R673H/+, and smyhc1R673H/R673H larvae display Smyhc1 in the
muscle fibers at 24 hpf. smyhc1/ larvae at 24 do not stain positively for Smyhc1. Scale bar represents 50 lm.
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abnormalities displayed in larval stages in smyhc1/ fish, a pheno-
type associated with later vertebral fusions in other mutant fish lines
(reviewed in Ellis et al, 2013a,b; Gray et al, 2014).
smyhc1R673H/+ adults have both spinal curvature and
vertebral fusions
Similar to the smyhc1/ fish, the smyhc1R673H/+ fish displayed
spinal curvatures in adulthood, but the fish were often shortened in
length (Figs 4A and EV2). In addition, the spinal curves developed
much earlier; notochord kinks and bends that were seen as early as
48 hpf often preceded the later development of structural vertebral
abnormalities (Figs 2A and 4B), much as those previously reported
in leviathan/col8a1a zebrafish mutants (Gray et al, 2014). Upon
observation of alizarin red stained bone, most smyhc1R673H/+ adults
were found to have moderate-to-severe vertebral abnormalities,
with complex and variable vertebral fusions often involving multi-
ple vertebrae and their jaws often had a closed mouth appearance
(Figs 4B and C, and EV3B). Similar to leviathan, the vertebral
fusions in smyhc1R673H/+ were present at regions of severe spinal
curve and were not detected in regions where the spine was
straight. Spinal curves were predominantly present in the lateral
plane and were nearly all restricted to the distal tail. However, we
noted that some smyhc1R673H/+ larvae with proximal notochord
kinks did not survive to adulthood, which suggests that the propen-
sity toward distal spinal curves may be due to a selection bias
rather than a developmental predisposition to distal scoliosis. These
data suggest that larval notochord abnormalities predispose
smyhc1R673H/+ fish to vertebral fusions in adulthood.
smyhc1 mutants have motor deficits
Because smyhc1 is a myosin heavy chain gene critical for motor
function, and because of the observed effects of smyhc1 mutations
on gross anatomy described above, we assessed the effects of
smyhc1 mutations on muscle function by quantifying the movement
of fish at various times during development. The smyhc1 gene is
expressed embryonically, as early as 10-13 somites as evidenced by
in situ hybridization (Rauch et al, 2003; Bessarab et al, 2008; Li
et al, 2020); therefore, we first assessed embryonic movements by
counting the number of light-induced twitches beginning at 24 hpf
when embryos first respond to light stimulation (Kokel & Peterson,
2011; Saint-Amant & Drapeau, 1998; Fig 5A). The smyhc1/
embryos were completely paralyzed up to 48 hpf, after which they
exhibited normal movements in response to light stimulation. There
was not a statistically significant difference between smyhc1R673H/+
and their wild-type siblings until 34 hpf, when mutants displayed a
slight decrease in the number of twitches (Fig 5A). At early stages
when muscle function was grossly measured as the ability to twitch
in response to light, the smyhc1R673H allele had only minimally
apparent effects while lack of Smyhc1 abolished muscle function in
early embryonic stages.
Motor function was also assessed at 6 dpf to determine later
effects of smyhc1 mutations (Fig 5B). Automated motion tracking
software was used to quantitatively measure spontaneous swim-
ming distance, which was not possible at earlier stages due to their
small size and transparency. The total distance traveled over
5 minutes was less in smyhc1R673H/+ larvae compared to their wild-
type siblings. The smyhc1/ larvae swam a significantly shorter
A B
Figure 2. Embryonic phenotypes of smyhc1 mutants.
A Morphologies of smyhc1+/+, smyhc1/+, and smyhc1/ embryos are grossly normal at 2 days postfertilization (dpf), despite complete paralysis of smyhc1/ embryos.
In contrast, the smyhc1R673H/+ embryos have notochord kinks in larval stages (arrow head), while smyhc1R673H/R673H embryos have much more severe notochord kinks
that compress and distort the body axis (arrow heads). The smyhc1R673H/ embryos completely phenocopy smyhc1R673H/R673H embryos.
B Quantification of smyhc1R673H embryonic phenotypes at 2 dpf. Representative examples of fish in each of the four phenotypic groups (normal, mild, moderate, and
severe) are shown in Fig EV3.
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distance than both of the other genotypes (Fig 5B). At larval stages,
it appears that the effects of smyhc1 mutations, even after apparent
downregulation of the gene, have an enduring effect on muscle
function and locomotion.
Muscle function was measured in adults at 6 months postfertil-
ization (mpf) by assessing endurance upon exposure to a gradually
escalating flow of water in a swim tunnel (Fig 5C). The
smyhc1R673H/+ fish fatigued in the swim tunnel sooner than
smyhc1+/+ and smyhc1/ fish. No significant difference was noted
in time spent swimming between the smyhc1+/+ and smyhc1/
fish (Fig 5D). While the smyhc1 allele had a more severe effect on
muscle function in larval stages compared to the smyhc1R673H allele,
this result provides evidence that smyhc1/ mutants recover a
normal degree of motor function in adulthood.
smyhc1 R673H mutants have disorganized muscle and shortened
myoseptal intervals
Because smyhc1 is the first and earliest myosin heavy chain expressed
in slow skeletal muscle (Devoto et al, 1996), we examined the effect
of mutant smyhc1 alleles on morphological muscle development.
Phalloidin-rhodamine was used to stain filamentous actin in
smyhc1+/+, smyhc1/, smyhc1R673H/+, and smyhc1R673H/R673H
larvae. At 24 hpf, the smyhc1/ muscle was highly disorganized and
had no distinguishable sarcomeres or myofibers (Fig 6A and C). Wavy
strands of filamentous actin and numerous puncta of actin bundles
were present (Fig 6A). In contrast, smyhc1R673H heterozygotes and
homozygotes formed sarcomeres, but the filamentous actin was
unevenly distributed across the myofiber, which occasionally had a
flared appearance near the myosepta (Fig 6A). At 3 dpf, discrete
sarcomeres became evident in smyhc1/ myofibers; however, they
were poorly aligned with each other and with the myosepta.
smyhc1/ larvae were also found to have centralized nuclei (Fig 6B
and D). Organized sarcomeres were also present in smyhc1R673H/+
muscle, but myofibers were thin, becoming bulbous at their termini,
leading to poorly defined myosepta. The smyhc1R673H/R673H myofibers
were also had poorly defined myoseptal boundaries; bundles of actin
were commonly observed (Fig 6B and D).
To better define the role of smyhc1 in sarcomere development, Z-
disks were labeled with anti-a-actinin antibodies. At 24 hpf, Z-disks
were assembled in smyhc1+/+, smyhc1R673H/+, and smyhc1R673H/
R673H larvae, while smyhc1/ larvae failed to develop any Z-disk
structure (Fig 6C). However, by 3 dpf, smyhc1/ larvae formed Z-
disk structures, with a disorganized appearance consistent with the
thin filament morphology (Fig 6D). We then quantified the distance
between Z-disks to determine whether sarcomere length was
affected by the R673H mutation or lack of Smyhc1. smyhc1R673H/
R673H and smyhc1R673H/+ genotypes displayed significantly shorter
sarcomere lengths compared to wild type at both 24 hpf and 3 dpf,
with a large range of sarcomere length variability in smyhc1R673H/
R673H larvae (Fig 6G and H). At 3 dpf, smyhc1/ fish displayed a
significantly shorter Z-disk interval than any other genotype.
To determine whether the smyhc1 alleles affected the overall somite
length as was previously observed in the hypercontractile accordion
mutant (Hirata et al, 2004), we measured the distance between
myosepta in slow skeletal muscle. Myoseptal intervals were signifi-
cantly reduced in smyhc1R673H/R673H and smyhc1R673H/+ muscle at 24
hpf and 3 dpf. smyhc1/ larvae did not display a shortened myoseptal
distance (Fig 6E and F). Because both the Z-disk interval and myosep-
tal interval are reduced in smyhc1R673H mutants, we hypothesize that
the shortened myoseptal interval results from increased tension short-
ening the length of the sarcomere, and subsequently the myofiber, as
was proposed for the accordion mutant (Hirata et al, 2004). Conver-
sely, the shortened Z-disk interval observed in smyhc1/ fish is not
accompanied by a shortened myoseptal distance. These data, in addi-
tion to the observed disorganization of sarcomere alignment in
smyhc1/ fish, suggest a different mechanism, perhaps in which the
structural effects caused by the lack of Smyhc1 result in both a short-
ened Z-disk interval and sarcomere misalignment.
Cell death in smyhc1R673H/R673H zebrafish
To explore the effects of the smyhc1 alleles on cell viability, larvae
at 24 hpf and 3 dpf were stained with Caspase-3 antibodies (Dalgin
et al, 2011; Dalgin & Prince, 2015). Increased signal of the cleaved
Caspase-3 protein indicates an activation of the apoptosis pathway
(Sorrells et al, 2013). While there was no difference in cleaved
Caspase-3 at 24hpf, smyhc1R673H/R673H larvae had increased cleaved
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Figure 3. The smyhc1R673H allele reduces survival in a dose-dependent
manner.
A Schema of in-crosses used to generate clutches for survival assay.
B The predicted mendelian (1:2:1) and experimental ratio of genotypes of
progeny from smyhc1R673H/+ in-crosses demonstrates survival at the
indicated ages. This ratio quickly skewed toward an overrepresentation of
smyhc1+/+ fish with no representation of smyhc1R673H/R673H after 5 dpf.
There is also dropout of smyhc1R673H/+ fish into adulthood. Number of fish
counted per group is indicated.
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Caspase-3 in the muscle tissue at 3dpf (Fig EV4). This suggests that
increased tissue stress and muscle cell morphological decline due to
the smyhc1R673H allele may lead to an increase in cell death in the
homozygous state.
Para-aminoblebbistatin rescues smyhc1R673H mutant phenotypes
To understand the proposed mechanism and explore new therapeu-
tic approaches to prevent contractures and disability in DA patients,
we evaluated the ability of select pharmacological agents to normal-
ize the phenotype of smyhc1R673H heterozygous and homozygous
embryos. Tricaine methanesulfonate, an anesthetic that acts as a
neuromuscular blocking agent by directly inhibiting neuronal
sodium channels (Attili & Hughes, 2014), was applied to dechorion-
ated embryos from 12 to 72 hpf. Although the drug completely
suppressed embryonic movement as expected, it failed to improve
the ventral body curvature or reduce the development of notochord
kinks in smyhc1R673H heterozygotes and homozygotes (Fig EV5A).
This suggests that the contractures observed in smyhc1R673H
mutants arise independently of stimulated muscle contraction, but
is alternatively intrinsic to the muscle, and present even without
neural stimulation.
Myosin ATPase inhibitors are being developed for the treat-
ment of cardiomyopathy caused by similar mutations of cardiac
myosin heavy chain genes (Green et al, 2016); therefore, we
sought to determine whether drugs that directly inhibit function
of myosin (Kovács et al, 2004) could reduce the adverse pheno-
typic effects of the smyhc1R673H allele. Blebbistatin, a myosin
ATPase inhibitor, which reduces actin–myosin affinity, was
applied to dechorionated embryos at a concentration of 25 lM
A
C
B
Figure 4. smyhc1 mutants exhibit skeletal abnormalities in adulthood.
A Gross morphology of smyhc1 mutant adults. Most smyhc1/ adult fish display dorsal tail curvature, while smyhc1R673H/+ adults have a shortened body axis and
variable spinal curves.
B Alizarin red staining of bone shows spinal curvature but no bony fusions in the skeleton of smyhc1/ adults, in contrast to the compression and fusion of vertebrae
seen in smyhc1R673H/+ adults. Distal tail regions are highlighted and enlarged.
C Quantification of skeletal phenotype severity in adults. Representative examples of fish in each of the four phenotypic groups (normal, mild, moderate, and severe) are
shown in Fig EV3. Scale bars represent a length of 5 mm.
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from 24 to 48 hpf (Wang et al, 2015). Blebbistatin prevented the
development of notochord kinks in both smyhc1R673H/+ and
smyhc1R673H/R673H embryos (Rauscher et al, 2018; Fig EV5B).
However, numerous developmental defects, including pericardial
edema, dorsal tail curvature, and small eyes, were observed in all
fish exposed to this drug, including wild-type larvae, consistent
with the known cytotoxic effects of blebbistatin that are indepen-
dent of its myosin inhibition (Várkuti et al, 2016).
A blebbistatin derivative, para-aminoblebbistatin, which is more
photostable and less cytotoxic (Várkuti et al, 2016), was therefore
applied to dechorionated embryos at 25 lM for 24 or 48 h, starting
at 24 hpf. While para-aminoblebbistatin does not share the cytotoxic
effects of blebbistatin, its effect on cardiac myosin appears to cause
lethal pericardial edema in both mutant and wild-type embryos
(Várkuti et al, 2016). However, similarly to blebbistatin, its effect
on skeletal myosin completely abolished notochord kinks and bends
in both smyhc1R673H/+ and smyhc1R673H/R673H embryos at 2 dpf
(Fig 7A). This effect persisted to 3 dpf (Fig 7B). The molecular
inhibition of actin–myosin interaction removes the ability of the
muscle to contract. This effect suppresses the smyhc1R673H pheno-
type, suggesting that the allele causes notochord kinking as a
secondary effect of constitutive myofiber contraction, independent
of neural stimulation.
Discussion
Understanding the functional consequences of MYH3 variants asso-
ciated with human disease has been limited by the lack of access to
human skeletal muscle tissue during embryonic development. The
recent description of multiple human skeletal muscle and bone
phenotypes associated with MYH3 variants, including autosomal
dominant and recessive spondylocarpotarsal synostosis syndromes,
in addition to DA, provides a strong motivation to develop animal
models to study and understand these variable phenotypes. By
generating two viable zebrafish smyhc1 alleles, including a smyhc1
null allele and a smyhc1R673H missense variant, we now have tools
to assess inheritance models and effects of gene dosage on pheno-
typic expression.
Our results not only confirm that the smyhc1R673H allele is more
severe than a smyhc1 null allele (which was also recently described
in Li et al, 2020), but also demonstrate the dosage sensitivity of the
missense allele to the wild-type allele, which modulates the effects
of the disease-causing R673H variant in our model system. Expres-
sion of the smyhc1R673H allele in the absence of a wild-type allele
resulted in embryos with a lethal phenotype identical to
smyhc1R673H/R673H embryos. Myosin is comprised of a hexamer
containing a pair of heavy chains, a pair of regulatory light chains,
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Figure 5. Motor deficits in smyhc1 mutants are variable during development.
A Time course of light-triggered larval movements was manually counted at indicated times between 24 and 48 hpf. The smyhc1/ larvae (n = 36) were paralyzed up
to 48 hpf. smyhc1R673H/+ mutants (n = 15) twitched slightly less than their smyhc1+/+ siblings (n = 21) at 34 hpf. The central bands of the boxplots represent the
median, the boxes of the boxplots represent the interquartile range (between the first and third quartile), and the whiskers represent the minimum and maximum
values, up to 1.5 times the interquartile range. Outliers displayed are outside of this range.
B Distance traveled during 5 min of spontaneous swimming at 6 dpf quantified by motion tracking software (Noldus Ethovision). At 6 dpf, both smyhc1/ (n = 24) and
smyhc1R673H/+ (n = 11) larvae traveled significantly less than smyhc1+/+ larvae (n = 13). The central bands of the boxplots represent the median, the boxes of the
boxplots represent the interquartile range (between the first and third quartile), and the whiskers represent the minimum and maximum values, up to 1.5 times the
interquartile range. Outliers displayed are outside of this range.
C Diagram of swim tunnel used to quantify adult swimming behavior. Water flow was gradually increased until the fish fatigued and were collected at the grate.
D Time spent swimming in swim tunnel before fatigue in adults at 6 months postfertilization (mpf). smyhc1+/+ (n = 6), smyhc1/ (n = 5), smyhc1R673H/+ (n = 5).
Data Information: Wilcoxon rank-sum test used to calculate significance. P-values comparing each group displayed above data. The central bands of the boxplots
represent the median, the boxes of the boxplots represent the interquartile range (between the first and third quartile), and the whiskers represent the minimum and
maximum values, up to 1.5 times the interquartile range. Outliers displayed are outside of this range.
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and a pair of essential light chains (Schiaffino & Reggiani, 1996).
Because of the dimerization of the myosin heavy chains, and subse-
quent assembly of the hexamers into the thick filament, it is reason-
able to hypothesize that compound heterozygosity of a missense
mutation in trans with a hypomorphic or null allele will increase the
phenotypic severity of afflicted individuals compared to a missense
mutation in trans with a wild-type allele. In fact, a Dutch study
recently identified a high impact MYH3 50 UTR variant with a
gnomAD minor allele frequency of 0.008 that diminishes MYH3
translational efficiency (Cameron-Christie et al, 2018). This variant
was reported in patients with presumed autosomal recessive
spondylocarpotarsal synostosis syndrome, demonstrating a biallelic
phenotype consisting of a haploinsufficient allele and a hypomor-
phic allele. This genotype exacerbated the severity of the disorder,
and our results in zebrafish similarly demonstrate that the pheno-
typic severity of an autosomal dominant allele is greater when in
trans with a hypomorphic than a wild-type allele. Because intrafa-
milial phenotypic variability has previously been reported in DA1
families with MYH3 mutations (Alvarado et al, 2011), we now
hypothesize that expression differences of the wild-type allele may
be responsible.
Zebrafish offer many practical advantages for research, including
accessibility at early time points in development due to their optical
clarity, speed of development, large clutch size, and convenient
external development. smyhc1 is the only myosin gene expressed
during early zebrafish embryogenesis; therefore, we hypothesized
that its manipulation would accurately model the human condition
(Devoto et al, 1996; Elworthy et al, 2008; Schiaffino et al, 2015).
Zebrafish also offer a unique opportunity to study slow skeletal
muscle development in isolation due to the spatial segregation of
slow and fast skeletal muscle in zebrafish, with the former develop-
ing as a thin border along the lateral aspect and the latter making up
the bulk of the trunk (Elworthy et al, 2008). In contrast, human
skeletal muscle is composed of interspersed slow and fast twitch
muscle fibers. Muscle hypercontractility in smyhc1R673H heterozy-
gous and homozygous fish was evidenced by the shortened slow
muscle sarcomere length, and shortened myoseptal interval that
phenocopies the accordion hypercontractile zebrafish mutant which
has a muscle relaxation defect due to a mutation in atp2a1 (sar-
coplasmic reticulum Ca2+-ATPase 1; Hirata et al, 2004). In our
model, some myofibers even appeared to physically dissociate from
the myosepta by flaring bulbously at the end of the myofiber, which
we hypothesize was a consequence of excessive biomechanical
force and may have contributed to increased apoptosis in the
homozygous smyhc1R673H larvae. This resembles the hypercontrac-
tile phenotype seen in Drosophila upon expression of the R672C
mutation, in which normal myofibril assembly is followed by
degeneration that ultimately results in a complete impairment of
flight (Rao et al, 2019).
One of the earliest morphological abnormalities that we observed
in smyhc1R673H heterozygous and homozygous mutant embryos was
prominent notochord kinks and bends. Results from our study
suggest that notochord abnormalities arise as a consequence of
excessive tension on the notochord due to hypercontraction and/or
uncoordinated contraction of the surrounding muscle. Data to
support this mechanism include the much more severe phenotype
seen in homozygous smyhc1R673H mutants, and the complete rescue
of this phenotype by treatment with the myosin ATPase inhibitor,
para-aminoblebbistatin. While the notochord abnormalities in the
accordion mutant were suppressed with drugs inhibiting neural
transmission (Hirata et al, 2004), the smyhc1R673H mutant noto-
chord defects could not be similarly suppressed, but improved only
when muscle contraction itself was directly impaired via myosin-
inhibiting drugs. Our in vivo results are consistent with prior in vitro
studies of both patient muscle tissue and C2C12 cells in which the
R673H variant was observed to negatively affect relaxation kinetics
(Racca et al, 2015; Walklate et al, 2016). As predicted by their
work, gross phenotypic abnormalities in our smyhc1R673H mutants,
including severe notochord kinks and bends, were completely abol-
ished after treatment with myosin inhibitors.
The phenotypic spectrum of MYH3-associated disease was
recently broadened to include vertebral fusions, which are a
◀ Figure 6. Slow skeletal muscle disorganization of smyhc1 mutants.A Confocal fluorescence images of slow skeletal muscle of 1 dpf larvae, stained with phalloidin-rhodamine to detect actin. Puncta of filamentous actin are indicated
with white arrowheads, and misshapen myofibers are indicated with white arrows and outlined.
B Confocal microscope fluorescence images of slow skeletal muscle of 3 dpf larvae, stained with phalloidin-rhodamine. Puncta of filamentous actin are indicated with
white arrowheads, distorted myofibers are indicated with arrows and outlined, and frayed myofibers are indicated with yellow arrowhead.
C Confocal fluorescence images of slow skeletal muscle of 1 dpf larvae, stained with phalloidin-rhodamine (red), anti-a-actinin antibodies (green), and DAPI (blue).
D Confocal fluorescence images of slow skeletal muscle of 3 dpf larvae, stained with phalloidin-rhodamine (red), anti-a-actinin antibodies (green), and DAPI (blue).
Bundle of actin ringed with a-actinin indicated with white-bordered black arrowhead.
E Myoseptal intervals of slow skeletal muscle at 1 dpf in smyhc1+/+ (n = 54), smyhc1/ (n = 31), smyhc1R673H/+ (n = 45), and smyhc1R673H/R673H (n = 49). Distance
between myosepta was measured perpendicular to rostral-caudal body axis at defined mid-body regions in phalloidin stained slow skeletal muscle fluorescence
images. The central bands of the boxplots represent the median, the boxes of the boxplots represent the interquartile range (between the first and third quartile), and
the whiskers represent the minimum and maximum values, up to 1.5 times the interquartile range. Outliers displayed are outside of this range.
F Myoseptal intervals of slow skeletal muscle at 3 dpf in smyhc1+/+ (n = 51), smyhc1/ (n = 32), smyhc1R673H/+ (n = 64), and smyhc1R673H/R673H (n = 38). The central
bands of the boxplots represent the median, the boxes of the boxplots represent the interquartile range (between the first and third quartile), and the whiskers
represent the minimum and maximum values, up to 1.5 times the interquartile range. Outliers displayed are outside of this range.
G Z-disk intervals (sarcomere length) of slow skeletal muscle at 1 dpf in smyhc1+/+ (n = 380), smyhc1R673H/+ (n = 293), and smyhc1R673H/R673H (n = 268). Distance
between z-disks was measured in anti-a-actinin stained slow skeletal muscle fluorescence images. The central bands of the boxplots represent the median, the boxes
of the boxplots represent the interquartile range (between the first and third quartile), and the whiskers represent the minimum and maximum values, up to 1.5
times the interquartile range. Outliers displayed are outside of this range.
H Z-disk intervals (sarcomere length) of slow skeletal muscle at 3 dpf in smyhc1+/+ (n = 249), smyhc1/ (n = 278), smyhc1R673H/+ (n = 246), and smyhc1R673H/R673H
(n = 252). The central bands of the boxplots represent the median, the boxes of the boxplots represent the interquartile range (between the first and third quartile),
and the whiskers represent the minimum and maximum values, up to 1.5 times the interquartile range. Outliers displayed are outside of this range.
Data Information: Wilcoxon rank-sum test used to calculate significance. P-values comparing each group displayed above data. Scale bars represent a length of 50 lm.
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defining clinical feature of spondylocarpotarsal synostosis syndrome.
Spondylocarpotarsal synostosis syndrome is associated with both
autosomal dominant and recessive inheritance; both missense and
nonsense MYH3 variants have been reported in recessive cases
(Carapito et al, 2016; Zieba et al, 2017; Cameron-Christie et al,
2018). Congenital spinal fusions were observed in our smyhc1R673H
mutants but not in smyhc1 null mutant fish, suggesting that bony
fusions in our missense model result secondarily from increased
tension generated by the mutant muscle protein, putting excessive
tension and stress on the notochord, causing it to kink. Gray et al
(2014) previously observed a direct spatial relationship between the
areas where notochord kinks were most severe and the location of
later developing vertebral fusions in leviathan/col8a1a null zebra-
fish. Thus, our current model supports a hypermorphic or neomor-
phic effect of the smyhc1R673H allele that causes increased muscle
tension, which in turn puts excessive stress on the notochord result-
ing in kinks that progress into vertebral fusions in adult fish. Others
have proposed alternative mechanisms for the development of
skeletal abnormalities in MYH3-associated disorders, including a
direct effect of its postnatal expression in vertebral bone (Zieba
et al, 2017). Furthermore, the postnatal persistence of MYH3 expres-
sion in the small multifidus muscles connecting to the neural arches
of the spine in mice was also proposed as a possible mechanism. It
is possible that abnormal mechanical forces imposed upon the inter-
vertebral disk by pathogenic MYH3 mutations functioning postna-
tally in these small muscle increase the vulnerability of the spine to
scoliosis and spinal fusions over time (Zieba et al, 2017). Further-
more, in cultured cells, MYH3 expression also activates TGF-b
signaling pathways that are associated with bone fusions in other
disease models (Zieba et al, 2017). Interestingly, we also note that
smyhc1 is expressed in zebrafish somites at the 5–9 somite stage
even prior to muscle development (Rauch et al, 2003; Bessarab
et al, 2008; Li et al, 2020); its role at this early time period is
unknown but may indicate a function independent from its role in
muscle. More work is needed to understand the how MYH3
mediates the complex developmental relationship between muscle
and bone.
Animal models are necessary to advance the development of
novel gene-directed therapies for patients with DA. Pharmacological
approaches for DA should be informed by research in hypertrophic
cardiomyopathy on the closely related cardiac myosin heavy chain
gene, MYH7 (Green et al, 2016). The R453 residue in MYH7 is anal-
ogous to the R673 residue targeted for mutation here in the zebra-
fish gene, smyhc1. Prior work has modeled the MYH7 R453C variant
in mice, demonstrating that treatment with cardiac specific myosin
inhibitors, including the small molecule MYK-461, reduces ventricu-
lar hypertrophy, cardiomyocyte disarray, and profibrotic gene
expression that are hallmarks of human hypertrophic cardiomyopa-
thy (Green et al, 2016). While inhibitors specific for embryonic
skeletal muscle myosin have not yet been reported, they would be
ideal drugs for the treatment and prevention of diseases associated
with MYH3 hypermorphic mutations. If MYH3-associated muscle
contractures or bone fusions result entirely from early embryonic
gene expression, then short drug treatments may be sufficient to
prevent progression of pathogenic phenotypes. Although our data
show that zebrafish with complete loss of smyhc1 expression have a
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Figure 7. Para-aminoblebbistatin ameliorates the smyhc1R673H larval phenotype.
A Representative morphologies of smyhc1+/+, smyhc1R673H/+, and smyhc1R673H/R673H larvae at 2 dpf after 24-h treatment with 0.25% DMSO (control) or 25 lM para-
aminoblebbistatin. All larvae treated with para-aminoblebbistatin develop a slight dorsal tail curve and pericardial edema regardless of genotype. All para-
aminoblebbistatin-treated smyhc1R673H/+ (n = 9) and smyhc1R673H/R673H (n = 3) larvae are indistinguishable from smyhc1+/+ unlike the untreated larvae which have
markedly curved or distorted body axis.
B Representative images of smyhc1+/+, smyhc1R673H/+, and smyhc1R673H/R673H larvae at 3 dpf after 48-h treatment with 0.25% DMSO (control) or 25 lM para-
aminoblebbistatin. All larvae treated with para-aminoblebbistatin develop a slight dorsal tail curve and pericardial edema regardless of genotype. Para-
aminoblebbistatin-treated smyhc1R673H/+ (n = 9) and smyhc1R673H/R673H (n = 3) larvae are indistinguishable from smyhc1+/+ unlike the untreated larvae which have
markedly curved or distorted body axis.
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milder phenotype than those with smyhc1R673H mutations, nonspeci-
fic inhibition of smyhc1 or MYH3 with antisense oligonucleotides
risks worsening the phenotype of patients with missense mutations,
as seen by the severe phenotype of smyhc1R673H/ mutants. There-
fore, any proposed antisense oligonucleotide therapy would need to
be designed specifically for each MYH3 pathogenic variant. Our
work supports the potential use of myosin ATPase inhibitors for the
treatment of MYH3-associated DA, but considerable challenges
remain, including elucidation of the optimal treatment period and
reduction of toxicity through the development of embryonic myosin
specific inhibitors.
Materials and Methods
Ethical statement
Husbandry and protocols for experiments involving zebrafish
(Danio rerio) have been reviewed and approved by the Institu-
tional Animal Care and Use Committee (IACUC) at Washington
University.
Zebrafish husbandry
Zebrafish (Danio rerio) were raised and maintained using standard
methods (Westerfield, 1995). Zebrafish were housed and handled
using protocols approved by the Institutional Animal Care and Use
Committee (IACUC) at Washington University.
TALEN (transcription activator-like effector nuclease) generation
of smyhc1 mutants
Left and right TALENs were designed to target the sites flanking
codon 673 of smyhc1, on exon 16. TALENs were generated using
the Golden Gate method as previously described (Cermak et al,
2011). Plasmids were acquired from the Golden Gate TALEN and
TAL Effector Kit (AddGene) and RVD repeat arrays were cloned into
pCS2TAL3DD and pCS2TAL3RR (AddGene). Plasmids were trans-
formed into DH5a competent cells (Invitrogen) and isolated using
the QIAprep Spin Miniprep Kit (Qiagen).
Subsequently, plasmids encoding the scaffold and RVD arrays
were linearized via restriction digest and 50-capped mRNA was
generated by in vitro transcription using the mMESSAGE
mMACHINE SP6 Transcription Kit (Life Technologies). Capped
mRNA was purified using the RNeasy Mini Kit (Qiagen). WT
embryos were collected, and 40–50 pg of pooled left and right
TALENs at equal concentrations were injected into the yolk of 1–4
cell stage embryos. Embryos were raised to adulthood, and sperm
and progeny of these fish were collected and sequenced with MiSeq
to screen for germline transmission.
Western blot of Smyhc1 protein
For each sample, 20 embryos were collected and dechorionated in a
37°C 1 mg/ml pronase egg water solution. Embryos were anes-
thetized and deyolked by agitating in deyolking buffer (55 mM
NaCl, 1.25 mM NaHCO3, 1.8 mM KCl, 2.7 mM CaCl2). Embryos
were then washed twice in wash buffer (10 mM Tris pH 8.5,
110 mM NaCl, 3.5 mM KCl, 2.7 mM CaCl2). Embryos were then
agitated in RIPA with complete protease inhibitor cocktail (Roche
Applied Sciences). 50 lg of each sample was loaded onto a sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE).
Proteins were transferred to PVDF transfer membrane (Immobilon)
for immunoblotting. Membranes were blocked in 5% skim milk for
1 h and incubated with antibody in 1% skim milk overnight at 4°C.
The embryonic myosin heavy chain antibody [F59 (Iowa Develop-
mental Studies Hybridoma bank)] (1:70) (Elworthy et al, 2008) was
used to stain Smyhc1. A GAPDH antibody (Thermo Scientific)
(1:500) was used as a loading control. Membranes were washed in
0.1% PBST (0.1% Tween-20 in PBS) and incubated with a
secondary anti-mouse antibody conjugated to horseradish peroxi-
dase and developed with a chemiluminescent substrate enhanced
chemiluminescence (GE Healthcare).
Genotyping of smyhc1R673H mutants
Individual fish were genotyped via DNA collection and PCR amplifi-
cation of the smyhc1 mutant region, with subsequent restriction
digest targeting to identify the R673H allele. DNA was extracted
from tissue samples in lysis buffer [0.1 M Tris, 0.005 M EDTA,
0.03% SDS, 0.2 M NaCl, 1% Proteinase K (New England Biolabs,
P8107S)] and incubated at 50°C for 16 h and 95°C for 10 min. A
fragment of DNA containing the R673H mutation was PCR-ampli-
fied. The amplified DNA was incubated with the restriction enzyme
ApaLI in CutSmart buffer (New England BioLabs; R0507S, B7204S)
for 16 h at 37°C, which cleaves smyhc1 R673H mutant DNA frag-
ments, allowing wild-type, homozygous, and heterozygous individ-
uals to be identified after separation on an agarose gel.
Alizarin red/Alcian blue skeletal staining
Adult zebrafish (1–2 years postfertilization, male and female) were
euthanized and fixed in 4% paraformaldehyde in PBS at room
temperature under agitation for 7 days. They were then incubated
in acetone overnight under agitation at room temperature. After
rinsing in water, they were then incubated overnight under agitation
in staining solution (0.015% Alcian Blue, 0.005% Alizarin Red, 5%
Glacial Acetic Acid, 59.5% Ethanol). The fish were rinsed once and
then for 30 min under agitation at room temperature in water. The
fish were incubated in 1% KOH under agitation at room tempera-
ture until the soft tissue became transparent, 1–3 weeks depending
on the size of the fish. The 1% KOH solution was replaced periodi-
cally. The fish were stored in glycerol, and the scales removed
manually if they had not fallen off during KOH clearing.
Phalloidin-rhodamine/DAPI/Immunohistochemistry muscle
staining and imaging
Zebrafish larvae 1–3 dpf were euthanized and fixed in 4%
paraformaldehyde in PBS overnight under agitation at 4°C. The
larvae were washed briefly and then twice for 30 min in PBD (0.1%
Tween-20, 0.3% Triton X-100, 1% DMSO in PBS) under agitation at
room temperature. The embryos were then incubated in block solu-
tion (0.1% Tween-20, 10% FBS, 2% BSA) at room temperature
under agitation for 60 min. Primary antibodies were added to
the block solution at the appropriate dilutions [F59 (Iowa
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Developmental Studies Hybridoma bank) 1:10; anti-Caspase 3
(Sigma-Aldrich AB3623) 1:100; anti-a-actinin (Sigma-Aldrich
A7811) 1:800; anti-phospho-SMAD2 (Sigma-Aldrich AB3849) 1:100]
and incubated overnight under agitation for 4°C. The solution was
removed, and the embryos were washed once quickly in PBD and
twice for 30 min under agitation at room temperature. The embryos
were then incubated in block solution for 60 min under agitation at
room temperature. The appropriate secondary antibody was added
to the block solution [Goat Anti-Rabbit IgG H&L (Alexa Fluor 488)
(Abcam ab150077) 1:500, Goat Anti-Mouse IgG (H&L) (Adsorbed
Against: Hu., Bv., Hs.) (DyLight 488) (Leinco M1331) 1:500], and
the embryos were incubated at 4°C overnight under agitation in the
dark. The solution was removed, and the embryos were washed
once quickly in PBD and incubated with DAPI (Sigma-Aldrich
D9542) at a dilution of 1:15,000 in PBST for 30 min under agitation
at room temperature. The solution was removed, and the embryos
were incubated in rhodamine phalloidin (Invitrogen 2009720) at a
dilution of 1:1,000 in PBD for 30 min at room temperature. The
embryos were then washed in PDB for 30 min at room temperature
and mounted on slides in glycerol under cover slips before imaging
under confocal microscopy. Confocal images of stained muscle were
analyzed in ImageJ to measure myosepta distance.
Microscopy
Confocal images were taken on an Olympus BX61WI fixed stage
microscope with Olympus Fluoview FV1000 confocal laser scan-
ning. Images were processed in ImageJ.
Drug treatment
Embryos were randomly chosen for control or experimental treat-
ment and dechorionated prior to drug treatment. Embryos were
immersed in 40 lg/ml tricaine methanesulfonate in egg water (5 mM
NaCl, 0.17 mM KCl, 0.33 mm CaCl2, MgSO4 in H2O), 25 lM blebbis-
tatin, or 25 lM para-aminoblebbistatin. Para-aminoblebbistatin in
DMSO was mixed with egg water to facilitate dissolution of blebbis-
tatin in aqueous buffer, generating 0.25% DMSO, 25 lM blebbistatin
in egg water. For the tricaine treatment, the egg water was replaced
every 24 h for 5 days. All incubations were performed in glass-
bottom dishes. Images of the embryos were taken periodically.
Noldus movement quantification
The Noldus DanioVision and EthoVision software were used to
record and quantify movement of zebrafish larvae at 6 dpf. Larvae
were acclimated in the DanioVision box for 5–10 min before using
swimming data for analysis. Embryos were loaded into the DanioVi-
sion in 12-well cell culture plates in replicates and placed in wells at
random. Five minutes of recorded behavioral data was analyzed for
the distance traveled. The EthoVision software tracked and recorded
fish movement data.
Light stimulated motor activity
Light stimuli were administered to zebrafish embryos which were
individually embedded in their chorions in an agarose mold. They
were kept in an opaque box in a 28.5°C incubator between
timepoints. At 17, 21, 24, 26, 28, 30, 32, 34, and 48 hpf, each mold
was placed on a dissecting microscope stage, and a video recording
was captured. The embryos were subjected to two cycles of 30 s in
the dark and 30 s under light stimulus, with a final 30-s dark period
afterward. The number of times each embryo twitched was counted
in each recording.
Swim tunnel quantification
Zebrafish were loaded into a swim tunnel with a steadily increasing
flow. Once an individual fish fatigued, it lay against the back grate
of the tunnel and was removed from the experiment to a separate
tank, and the time to fatigue was recorded. After acclimating with
no flow, the fish were subjected to 10 cm/s flow for 1 min. The flow
then increased by 2 cm/s every minute until every fish fatigued.
Statistical analysis
Differences in number of twitches, distance traveled, a-actinin inter-
vals, and myoseptal intervals were quantified using nonparametric
tests (Wilcoxon rank-sum test), so normal distribution was not
assumed in the statistical tests. An estimate of variation was not
included in the statistical analysis, but seems to vary between
compared groups. R was used to analyze data and generate graphs.
Sample size was determined based on experience from previous
findings and animal availability. Depending on the nature and
The paper explained
Problem
The debilitating joint contractures that are characteristic of distal
arthrogryposis (DA) syndromes are currently suboptimally treated with
supportive care. Understanding how dominant or recessive MYH3
mutations cause contractures or bony fusions has been limited by
poor access to human tissue, particularly during early development
when MYH3 is most highly expressed. Previous single-cell and small
molecule studies suggest that DA mutations cause muscle hypercon-
traction, but vertebrate models are required to study the complex
interactions between bone and muscle and to develop novel targeted
therapeutics.
Results
Zebrafish carrying a single copy of the most common DA-associated
MYH3 substitution (R672H) displayed notochord bends that developed
into scoliosis and vertebral fusions in adulthood, shortened sarcom-
eres and muscle fibers, and impaired swimming capacity. The direct
chemical inhibition of muscle contraction with the myosin ATPase
inhibitor para-aminoblebbistatin prevented the notochord bends from
developing in both heterozygous and homozygous fish, suggesting
that the mutant allele causes notochord and vertebral abnormalities
through a mechanical increase in muscle tension.
Impact
We developed a viable zebrafish model of DA that is dually useful for
both mechanistic studies and therapeutic drug development. Our
work suggests that muscle hypercontractility mediated by the MYH3
mutation secondarily leads to vertebral fusions highlights the inter-
connectedness of the muscular and skeletal systems during early
development. Furthermore, we have shown the beneficial effects of
myosin ATPase inhibitors for the treatment of DA.
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complexity of the assay, the maximum number of animals that
could be tested was used to increase statistical power as much as
possible. No samples were excluded from analysis. Zebrafish were
chosen at random as subjects before genotype was determined.
When determining survivability of zebrafish genotypes, entire
clutches were genotyped to avoid selective bias. The investigator
was not blinded before assessing skeletal, muscular, or gross
anatomical abnormalities of zebrafish.
Data availability
The zebrafish lines discussed in this paper are available upon request.
No novel software was developed for the purposes of this study. No
protein, DNA, or RNA sequence; Macromolecular structure; Crystollo-
graphic; Functional Genomics; or Proteomics and molecular interac-
tion datasets were collected for the purposes of this study. This study
includes no data deposited in external repositories.
Expanded View for this article is available online.
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